Cardiovascular Systems (CSII) Tops Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cardiovascular Systems (CSII) PT Raised to $32 at Needham & Company Following 2Q Earnings Report
January 26, 2017 7:22 AM ESTNeedham & Company raised its price target on Cardiovascular Systems (NASDAQ: CSII) to $32.00 (from $27.00) while maintaining a Buy rating following the company's 2Q earnings report. Revenue was $50.0M vs. consensus of $49.6M and EPS was $0.03 vs. consensus of ($0.06).
Analyst Mike Matson commented,... More
